State Legislative Update: Breast Health Legislation
Specific topics include measures to eliminate patient cost sharing and repeal or revision of existing breast density notification.
Read moreMain Content
FDA Releases Final Guidance For MQSA Regulation Changes Effective Sept. 10
Aug. 29, 2024
The U.S. Food and Drug Administration (FDA) this week provided notice of final guidance issued by the Center for Devices and Radiological Health, Mammography Quality Standards Act (MQSA) and Regulation Amendments: Small Entity Compliance Guide (SECG). The FDA developed the SECG to explain the actions a small entity must take to comply with the MQSA rule and its implementing regulations.
The March 2023 MQSA rule modernized mammography regulations and specifies that the mammography report given to patients specifies if they have dense or non-dense breast tissue; it includes a prescribed paragraph on the significance of breast density.
The FDA prepared the SECG to help small entities comply with MQSA regulation changes, which take effect Sept. 10.
For more information, contact Katie Grady, American College of Radiology® Government Affairs Director.
The March 2023 MQSA rule modernized mammography regulations and specifies that the mammography report given to patients specifies if they have dense or non-dense breast tissue; it includes a prescribed paragraph on the significance of breast density.
The FDA prepared the SECG to help small entities comply with MQSA regulation changes, which take effect Sept. 10.
For more information, contact Katie Grady, American College of Radiology® Government Affairs Director.
Related ACR News
HRSA Breast Cancer Screening for Average Risk Guideline
The U.S. Department of Health and Human Services Health Resources and Services Administration finalized its proposal for the Breast Cancer Screening for Women at Average Risk guideline.
Read moreACR Comments on Draft HRSA Breast Cancer Screening Recommendations
The American College of Radiology® (ACR®) submitted comments this week on draft recommendations for the Health Resources and Services Administration (HRSA)-supported Women's Preventive Services Guidelines , including for breast cancer screening.
Read more